Similar Search Results

The Impact of New Drug Launches on Longevity : Evidence from Longitudinal Disease-Level Data from 52 Countries, 1982-2001

Lichtenberg, Frank R. - 2021

We perform an econometric analysis of the effect of new drug launches on longevity, using data from the IMS Health Drug Launches database and the WHO Mortality Database. Our data cover virtually all of the diseases borne by people in 52 countries during the period 1982-2001, and enable us to...

Persistent link: https://www.econbiz.de/10013245298

The Allocation of Publicly-Funded Biomedical Research

Lichtenberg, Frank R. - 2021

We develop a simple theoretical model of the allocation of public biomedical research expenditure, and present some empirical evidence about the determinants of this allocation. The structure of expenditure should depend on the relative costs as well as the relative benefits of different kinds...

Persistent link: https://www.econbiz.de/10013219295

International R&D Spillovers : A Re-Examination

Lichtenberg, Frank R.; van Pottelsberghe de la … - 2021

Coe and Helpman(1995) have measured the extent to which technology spills over between industrialized countries through the particular channel of trade flows. This paper re-examines two particular features of their study. First, we suggest that their functional form of how foreign R&D affects...

Persistent link: https://www.econbiz.de/10013221859

The Effect of Changes in Drug Utilization on Labor Supply and Per Capita Output

Lichtenberg, Frank R. - 2021

We hypothesize that pharmaceutical-embodied technical progress increases per capita output via its effect on labor supply (the employment rate and hours worked per employed person). We examine the effect of changes in both the average quantity and average vintage (FDA approval year) of drugs...

Persistent link: https://www.econbiz.de/10013222635

Sources of U.S. Longevity Increase, 1960-1997

Lichtenberg, Frank R. - 2021

models using annual U.S. time-series data on life expectancy, health expenditure, and medical innovation. Reliable annual … data are available for only one type of innovation - new drugs - but pharmaceutical R&D accounts for a significant fraction … innovation (in the form of new drug approvals) and expenditure on medical care (especially public expenditure) contributed to …

Persistent link: https://www.econbiz.de/10013224922

The Effect of Education on Medical Technology Adoption : Are the More Educated More Likely to Use New Drugs

Lleras-Muney, Adriana; Lichtenberg, Frank R. - 2021

There is a large body of work that documents a strong, positive correlation between education and measures of health, but little is known about the mechanisms by which education might affect health. One possibility is that more educated individuals are more likely to adopt new medical...

Persistent link: https://www.econbiz.de/10013248387

The Impact of Biomedical Knowledge Accumulation on Mortality : A Bibliometric Analysis of Cancer Data

Lichtenberg, Frank R. - 2014

I examine the relationship across diseases between the long-run growth in the number of publications about a disease and the change in the age-adjusted mortality rate from the disease. The diseases analyzed are almost all the different forms of cancer, i.e. cancer at different sites in the body...

Persistent link: https://www.econbiz.de/10013062348

Training, Tenure, and Productivity

Lichtenberg, Frank R. - 2021

for estimation of the marginal productivity of workers classified by length of service to the firm, i.e., of the tenure …

Persistent link: https://www.econbiz.de/10013230222

Industrial De-Diversification and its Consequences for Productivity

Lichtenberg, Frank R. - 2021

Due in large part to intense takeover activity during the 1980s, the extent of American firms' industrial diversification declined significantly during the second half of the decade. The mean number of industries in which firms operated declined 14 percent, and the fraction of single-industry...

Persistent link: https://www.econbiz.de/10013230386

Pharmaceutical Innovation and Longevity Growth in 30 Developing and High-Income Countries, 2000-2009

Lichtenberg, Frank R. - 2014

I examine the impact of pharmaceutical innovation, as measured by the vintage (world launch year) of prescription drugs …

Persistent link: https://www.econbiz.de/10013065798